vancomycin hydrochloride
- Product NDC
- 59651-670
- Requested package NDC
- 59651-670-55
- 11-digit product format
- 596510670
- Labeler code
- 59651
- Product ID
- 59651-670_e1008de0-8530-4998-8f8e-7d302e437e4f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- vancomycin hydrochloride
- Dosage form
- KIT
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA218130
- Marketing category
- ANDA
- Marketing start
- 2026-08-07
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218130-001 | VANCOMYCIN HYDROCHLORIDE | VANCOMYCIN HYDROCHLORIDE | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | AA | 2026-08-07 | |
| A218130-002 | VANCOMYCIN HYDROCHLORIDE | VANCOMYCIN HYDROCHLORIDE | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | AA | 2026-08-07 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218130-001 | AA |
| A218130-002 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218130-001 | VANCOMYCIN HYDROCHLORIDE | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | AA | 2026-08-07 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A218130-002 | VANCOMYCIN HYDROCHLORIDE | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | AA | 2026-08-07 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A218130-001 | VANCOMYCIN HYDROCHLORIDE | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | AA | 2026-08-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A218130-002 | VANCOMYCIN HYDROCHLORIDE | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | AA | 2026-08-07 | caaa826d4ba7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218130-001 | AA | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A218130-002 | AA | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A218130-001 | AA | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A218130-002 | AA | 1 | caaa826d4ba7… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- vancomycin hydrochloride
- Listing expiration
- 2027-12-31
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| e1008de0-8530-4998-8f8e-7d302e437e4f | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| vancomycin hydrochloride | VANCOMYCIN HYDROCHLORIDE | Aurobindo Pharma Limited | e1008de0-8530-4998-8f8e-7d302e437e4f | 2026-08-17 | Warnings, Adverse reactions | 218130 ANDA218130 59651-670-55 59651-670 59651067055 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 59651-670-55 | 59651067055 | 1 KIT in 1 CARTON (59651-670-55) * 145 mL in 1 BOTTLE * 15 g in 1 BOTTLE * 289 mL in 1 BOTTLE * 7.5 g in 1 BOTTLE | 1 kit | 2026-08-07 | No | No | Current |